CAMFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Condition:   Desmoplastic Small Round Cell Tumor Interventions:   Drug: Ramucirumab;   Drug: Cyclophosphamide;   Drug: Vinorelbine Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials